RecruitingPhase 1 / Phase 2NCT06783309
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Sponsor: COUR Pharmaceutical Development Company, Inc.
Austin, TX · Dallas, TX · Humble, TX · +42 more sites